Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

In small cap land when you have been listed for 20 years your share price matters. Its all that matters and this one clearly shows chronic under performance. Its not like there has been a change of management, its the same stock, the same team, the same results.

You bring the pandemic up as if its a negative. Remember when it started this was going to be driver for UCM, the device was critical to treating covid patients. They even said they had a calibration device for ventilators. How many sales so far? It was meant to have a clear path way to market remember? So now the pandemic is an excuse for not selling?

My comment re the CR was that it has not helped to grow the shareholder base, in reality it has simply given the top shareholders more control. They have no broker or fund manager support (Jetan has been there for ever), they are force multipliers, ie can push/support a stock. It goes to the management having no presence with the market.

Impatient? As noted the stock has been listed for 20 years, nearly everyone is under water. You talk as it if listed 12 months ago it has not, its been spinning this story for nearly 20 years.

I have no expectations at all Bill, I wait for information, I assess that, I watch the market and I make calls based on that. I get it right sometimes, more often wrong but that;s investing. I cut the losers and move on.

In the case of a stock like UCM talk is cheap, its about delivery, any good will the market may have once had for them is long gone, its all about the numbers now.

But look on the bright side, there will some price strength as even a broken clock is right twice a day. I've no doubt you will get your chance to cash in.